Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2014


World Vaccine Congress Washington 2014

24 Mar 2014 - 26 Mar 2014 - Washington, DC, USA



Bookmark and Share


The 14th annual World Vaccine Congress Washington is a proven conference and exhibition that delivers the innovators, disruptors and influencers from across the complete vaccine value chain.
This event brings together government, big pharma, big biotech, SME Biotech, academia, government and the wider service provider community and their partners to discuss scientific, clinical and strategic advances and opportunities.
Having brought together over 5000 stakeholders in its 13 year history, this event provides the link between scientific development and commercialisation.

This conference is produced to facilitate high level on the topics that matter to the industry right now/ Major congress themes include, but are not limited to:
Governmental immunisation plans
NGO engagement 
Innovative / disruptive R&D models
Clinical / translational research
Therapeutic / prophylactic vaccine markets
Infectious / non-infectious disease research
Emerging market opportunities
Emerging / re-emerging epidemics
Novel technologies
Production / manufacture
Regulation / authorization
Safety / efficacy
Pricing / reimbursement / market access

Blog: http://blogs.terrapinn.com/vaccinenation/ Twitter hashtag: #wvcusa


Further information
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!